Immune control in experimental subacute sclerosing panencephalitis.
D000818:Animals; D000914:Antibodies, Viral / Q000096:biosynthesis; D000956:Antigens, Viral / Q000302:isolation & purification; D001812:Blood-Brain Barrier; D002648:Child; D002675:Child, Preschool; D003165:Complement System Proteins / Q000134:cerebrospinal fluid / Q000502:physiology; D000882:Haplorhini; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000209:etiology; D008253:Macaca mulatta; D008457:Measles / Q000150:complications; D008459:Measles virus / Q000276:immunology / Q000502:physiology / Q000648:ultrastructure; D009103:Multiple Sclerosis / Q000209:etiology / Q000276:immunology; D009474:Neurons / Q000648:ultrastructure; D013344:Subacute Sclerosing Panencephalitis / Q000209:etiology / Q000276:immunology* / Q000382:microbiology / Q000503:physiopathology
D000914:Antibodies, Viral; D000956:Antigens, Viral; D003165:Complement System Proteins